Make Better Decisions - Finding and Evaluating Generic and Branded Drug Market Entry Opportunities

Get the Book: Make Better Decisions

Finding and Evaluating Generic and Branded Drug Market Entry Opportunities

PDF eBook: Just $10 Get Print Book on Amazon

Serving hundreds of leading biopharmaceutical companies globally:

Farmers Insurance
Deloitte
Merck
US Department of Justice
Covington
Argus Health

Generated: July 23, 2019

DrugPatentWatch Database Preview

Loxapine succinate - Generic Drug Details

Try a free trialSee Plans and Pricing

« Back to Dashboard

What are the generic sources for loxapine succinate and what is the scope of loxapine succinate freedom to operate?

Loxapine succinate is the generic ingredient in two branded drugs marketed by Elite Labs Inc, Lannett Co Inc, Mylan, Watson Labs, and Teva Branded Pharm, and is included in eight NDAs. Additional information is available in the individual branded drug profile pages.

There are eight drug master file entries for loxapine succinate. Eight suppliers are listed for this compound.

Synonyms for loxapine succinate
(E)-2-chloro-11-(4-methylpiperazin-1-yl)dibenzo[b,f][1,4]oxazepine succinate
1977-10-2 (Parent)
2-Chloro-11-(4-methyl-1- piperazinyl)-dibenz[b,f][1,4]- oxazepine succinate
2-Chloro-11-(4-methyl-1-piperazinyl)dibenz(b,f)(1,4)oxazepine succinate (1:1)
2-Chloro-11-(4-methyl-1-piperazinyl)dibenz[b,f][1,4]oxazepine, Succinate
2-chloro-11-(4-methyl-1-piperazinyl)dibenzo[b,f][1,4]oxazepine succinate
27833-64-3
833L643
AC1L2G38
AC1Q5VQU
AKOS015994711
AOB5330
AZ-004
AZ-104
Butanedioic acid, compd. with 2-chloro-11-(4-methyl-1-piperazinyl)dibenz(b,f)(1,4)oxazepine (1:1)
Butanedioic acid, compd. with 2-chloro-11-(4-methyl-1-piperazinyl)dibenz[b,f][1,4]oxazepine (1:1)
butanedioic acid; 8-chloro-6-(4-methylpiperazin-1-yl)benzo[b][1,4]benzoxazepine
butanedioic acid;8-chloro-6-(4-methylpiperazin-1-yl)benzo[b][1,4]benzoxazepine
C-54162
C22H24ClN3O5
CAS-27833-64-3
CCG-39497
CCRIS 1917
CHEBI:6549
CHEMBL1201155
CL 71563
CL-71563
Cloxazepin
CPD000058470
CS-4285
CTK4G0318
D00794
Daxolin
DSSTox_CID_25227
DSSTox_GSID_45227
DSSTox_RID_80764
DTXSID3045227
EINECS 248-682-0
EU-0100720
FT-0653022
HMS1568K06
HMS1922L14
HMS2051E05
HMS2093N20
HMS2095K06
HMS2232N05
HMS3262O21
HMS3374F02
HMS3393E05
HMS3652O10
HMS3712K06
HY-17390A
KS-1083
Lederle
Lopac-L-106
Loxapac
Loxapine (succinate)
Loxapine succinate (USP)
Loxapine succinate [USAN:USP]
Loxapine succinate [USAN]
Loxapine succinate salt
Loxapine succinate salt, solid
Loxapine succinate, United States Pharmacopeia (USP) Reference Standard
Loxapine, Succinate
Loxapine,succinate
Loxipine Succinate
Loxitane (TN)
LP00720
LS-147408
MFCD00069298
MLS000069383
MLS000758291
MLS001146961
MLS001401432
MLS002222201
MolPort-003-666-776
NC00011
NCGC00016160-01
NCGC00016160-02
NCGC00016160-03
NCGC00016160-04
NCGC00016160-05
NCGC00021145-11
NCGC00094068-01
NCGC00094068-02
NCGC00094068-03
NCGC00261405-01
NSC-759578
NSC759578
O287
Opera_ID_1518
Pharmakon1600-02300242
Prestwick_304
REGID_for_CID_71399
s4086
SAM001247061
SCHEMBL41643
SMR000058470
SPECTRUM2300242
SR-01000002971
SR-01000002971-2
SR-01000002971-6
SR-01000002971-9
Staccato-loxapine
Succinic acid, compd. with 2-chloro-11-(4-methyl-1-piperazinyl)dibenz(b,f)(1,4)oxazepine (1:1)
Succinic acid, compound with 2-chloro-11-(4-methylpiperazin-1-yl)dibenz(b,f)(1,4)oxazepine (1:1)
SUM-3170
SW196603-4
Tox21_110311
Tox21_110311_1
Tox21_500720
UNII-X59SG0MRYU
VA11204
VU0239541-8
W-107092
X59SG0MRYU
ZX-AFC001324

US Patents and Regulatory Information for loxapine succinate

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Watson Labs LOXAPINE SUCCINATE loxapine succinate CAPSULE;ORAL 072204-001 Jun 15, 1988 AB RX No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Teva Branded Pharm LOXITANE loxapine succinate CAPSULE;ORAL 017525-003 Approved Prior to Jan 1, 1982 DISCN Yes No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Lannett Co Inc LOXAPINE SUCCINATE loxapine succinate CAPSULE;ORAL 090695-003 Sep 26, 2011 AB RX No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Lannett Co Inc LOXAPINE SUCCINATE loxapine succinate CAPSULE;ORAL 090695-001 Sep 26, 2011 AB RX No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Teva Branded Pharm LOXITANE loxapine succinate TABLET;ORAL 017525-006 Approved Prior to Jan 1, 1982 DISCN Yes No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Elite Labs Inc LOXAPINE SUCCINATE loxapine succinate CAPSULE;ORAL 076868-004 Aug 4, 2005 AB RX No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Watson Labs LOXAPINE SUCCINATE loxapine succinate CAPSULE;ORAL 072206-001 Jun 15, 1988 AB RX No Yes ➤ Sign Up ➤ Sign Up ➤ Sign Up
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

Subscribe to access the full database, or try a Free Trial

Expired US Patents for loxapine succinate

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Teva Branded Pharm LOXITANE loxapine succinate CAPSULE;ORAL 017525-001 Approved Prior to Jan 1, 1982 ➤ Sign Up ➤ Sign Up
Teva Branded Pharm LOXITANE loxapine succinate CAPSULE;ORAL 017525-003 Approved Prior to Jan 1, 1982 ➤ Sign Up ➤ Sign Up
Teva Branded Pharm LOXITANE loxapine succinate CAPSULE;ORAL 017525-004 Approved Prior to Jan 1, 1982 ➤ Sign Up ➤ Sign Up
Teva Branded Pharm LOXITANE loxapine succinate CAPSULE;ORAL 017525-002 Approved Prior to Jan 1, 1982 ➤ Sign Up ➤ Sign Up
Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration

Subscribe to access the full database, or try a Free Trial

Make Better Decisions: Try a trial or see plans & pricing

Serving hundreds of leading biopharmaceutical companies globally:

UBS
McKesson
QuintilesIMS
Express Scripts
Daiichi Sankyo
Argus Health

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.